Results 21 to 30 of about 1,314,101 (263)

Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution

open access: yesVaccines, 2022
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread to more than 230 countries and territories worldwide since its outbreak in late 2019. In less than three years, infection by SARS-CoV-2 has
Lili Li   +8 more
doaj   +1 more source

Study on thedistribution of high titer neutralizing antibody against human cytomegalovirus in plasma donors

open access: yesZhongguo shuxue zazhi, 2022
Objective To investigate the distribution of plasma donors with high titer neutralizing antibodies against human cytomegalovirus (HCMV) in the general plasma donor population. Methods 920 plasma samples of Taibang were tested in April 2014 to investigate
Junying SHEN   +5 more
doaj   +1 more source

Biological Activities of Natural Products [PDF]

open access: yesMolecules, 2020
Natural products and their biological activities are currently a subject of great interest in the pharmaceutical, health food, and cosmetics industries, and numbers of scientific studies in this field are increasing rapidly [...]
Halina Maria Ekiert, Agnieszka Szopa
openaire   +3 more sources

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments

open access: yesViruses, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social and economic distress. Given its rapid spread and the lack of specific treatment options, SARS-CoV-2 needs to be inactivated according to strict biosafety measures during
Shouzhi Yu   +12 more
doaj   +1 more source

Integrated Multi-Omic Characterization of the Detachment Process of Adherent Vero Cells with Animal-Based and Animal-Origin-Free Enzymes

open access: yesCells, 2022
Cell detachment techniques using animal-derived enzymes are necessary for the production of biopharmaceuticals that are made with the help of adherent cell cultures, although the majority of protein therapeutics (>USD 100 billion of income per year) are ...
Shouzhi Yu   +10 more
doaj   +1 more source

Trends in Biological Ammonia Production

open access: yesBioTech, 2023
Food production heavily depends on ammonia-containing fertilizers to improve crop yield and profitability. However, ammonia production is challenged by huge energy demand, the release of ~2% of global CO2, and political instability. To mitigate this challenge, many research efforts have developed bioprocessing technologies to make biological ammonia ...
Adewale Adeniyi   +4 more
openaire   +3 more sources

Reporter Coxsackievirus A5 Expressing iLOV Fluorescent Protein or Luciferase Used for Rapid Neutralizing Assay in Cells and Living Imaging in Mice

open access: yesViruses, 2023
Coxsackievirus A5 (CV-A5) is a re-emerging enterovirus that causes hand, foot, and mouth disease in children under five years of age. CV-A5-M14-611 is a mouse-adapted strain that can infect orally and lead to the death of 14-day-old mice.
Wei-Ping Jin   +7 more
doaj   +1 more source

Correction: Yu et al. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments. Viruses 2022, 14, 1938

open access: yesViruses, 2023
In the original publication [...]
Shouzhi Yu   +12 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy